Search Within

Dmitriy Zamarin

  1. "Melanoma Disease Management Team"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
  3. Guidelines (1)
Groups
  1. Department of Medicine (7)
  2. GDMT, Medicine (7)
  3. Gynecologic Medicine Service (7)
  4. Gynecology Disease Management Team (7)
  5. Melanoma Disease Management Team (7)
  6. Solid Tumor Oncology Division (7)

More Groups

People
  1. Anuradha Gopalan (4)
  2. Diane Reidy (4)
  3. Eileen O'Reilly (4)
  4. Michael Berger (4)
  5. Nitya Raj (4)
  6. Brian Untch (3)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (2)
  4. 2019 (2)
  5. 2015 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Cell (1)
  3. JNCI: Journal of the National Cancer Institute (1)
  4. Nature (1)
  5. Pancreas (1)
  6. Pharmacology & Therapeutics (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Cell Press (1)
  3. Elsevier Inc. (1)
  4. Lippincott Williams & Wilkins (1)
  5. Nature Publishing Group (1)
  6. Oxford University Press (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Recommendations for testing and treating outpatient cancer patients in the era of COVID-19
    Guidelines

    Reidy-Lagunes, D.; Saltz, L.; Postow, M.; Scordo, M.; Moskowitz, A.; Tew, W.; Zamarin, D.; Redelman-Sidi, G.
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • PD-1 blockade in advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J.; Do, R.; Capanu, M.; Zamarin, D.; Saltz, L.; Ariyan, C.; more...
    Pancreas (2020)

    Fulltext@MSK | Save
  • PD-1 blockade in advanced adrenocortical carcinoma
    Journal Article

    Raj, N.; Zheng, Y.; Kelly, V.; Katz, S. S.; Chou, J.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Saltz, L. B.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N. P.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J. F.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Ariyan, C. E.; Untch, B. R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • TOX is a critical regulator of tumour-specific T cell differentiation
    Journal Article

    Scott, A. C.; Dündar, F.; Zumbo, P.; Chandran, S. S.; Klebanoff, C. A.; Shakiba, M.; Trivedi, P.; Menocal, L.; Appleby, H.; Camara, S.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Immune checkpoint modulation: Rational design of combination strategies
    Journal Article

    Zamarin, D.; Postow, M. A.
    Pharmacology & Therapeutics (2015)

    Fulltext@MSK | Save